Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$151M |
| 2 |
GE Vernova
GEV
|
+$139M |
| 3 |
Ferrovial SE
FER
|
+$60.1M |
| 4 |
Strategy Inc Common Stock Class A
MSTR
|
+$24M |
| 5 |
Solventum
SOLV
|
+$22.9M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$184M |
| 2 |
GE Aerospace
GE
|
+$135M |
| 3 |
Apple
AAPL
|
+$117M |
| 4 |
Microsoft
MSFT
|
+$110M |
| 5 |
Meta Platforms (Facebook)
META
|
+$80.5M |
Sector Composition
| 1 | Technology | 33.84% |
| 2 | Healthcare | 12.16% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Communication Services | 9.35% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2176
JetBlue
JBLU
$1.85B
| $1,000K | ﹤0.01% |
164,200
| – | – |
|
2177
EverQuote
EVER
$849M
| $999K | ﹤0.01% |
+47,900
| New | +$999K |
|
2178
Cassava Sciences
SAVA
$101M
| $997K | ﹤0.01% |
80,700
+2,100
| +3% | +$25.9K |
|
2179
Diebold Nixdorf
DBD
$2.18B
| $997K | ﹤0.01% |
25,900
+3,700
| +17% | +$142K |
|
|
PTVE
2180
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $994K | ﹤0.01% |
87,800
| – | – |
|
2181
SI-BONE Inc
SIBN
$676M
| $993K | ﹤0.01% |
76,800
+4,900
| +7% | +$63.4K |
|
|
TRTX
2182
TPG RE Finance Trust
TRTX
$744M
| $993K | ﹤0.01% |
114,900
| – | – |
|
2183
Forward Air
FWRD
$913M
| $990K | ﹤0.01% |
52,000
+1,300
| +3% | +$24.8K |
|
2184
MetroCity Bankshares
MCBS
$742M
| $986K | ﹤0.01% |
37,362
| – | – |
|
2185
Orthofix Medical
OFIX
$563M
| $976K | ﹤0.01% |
73,600
+8,300
| +13% | +$110K |
|
2186
Navitas Semiconductor
NVTS
$1.2B
| $970K | ﹤0.01% |
246,700
| – | – |
|
|
CRON
2187
Cronos Group
CRON
$969M
| $968K | ﹤0.01% |
415,400
| – | – |
|
2188
nLIGHT
LASR
$1.44B
| $965K | ﹤0.01% |
88,300
+1,300
| +1% | +$14.2K |
|
2189
Equity Bancshares
EQBK
$809M
| $964K | ﹤0.01% |
27,381
| – | – |
|
2190
MeridianLink
MLNK
$1.47B
| $963K | ﹤0.01% |
45,100
+6,400
| +17% | +$137K |
|
|
SAGE
2191
DELISTED
Sage Therapeutics
SAGE
| $962K | ﹤0.01% |
88,600
-17,600
| -17% | -$191K |
|
|
TELL
2192
DELISTED
Tellurian Inc.
TELL
| $959K | ﹤0.01% |
1,384,900
+58,500
| +4% | +$40.5K |
|
|
BFS
2193
Saul Centers
BFS
$779M
| $955K | ﹤0.01% |
25,983
| – | – |
|
2194
Regenxbio
RGNX
$483M
| $954K | ﹤0.01% |
81,500
| – | – |
|
2195
Pliant Therapeutics
PLRX
$104M
| $950K | ﹤0.01% |
88,400
| – | – |
|
2196
Camden National
CAC
$679M
| $946K | ﹤0.01% |
28,661
| – | – |
|
2197
Quanterix
QTRX
$201M
| $945K | ﹤0.01% |
71,500
+1,200
| +2% | +$15.9K |
|
2198
OrthoPediatrics
KIDS
$484M
| $943K | ﹤0.01% |
32,800
+600
| +2% | +$17.3K |
|
|
NOA
2199
North American Construction
NOA
$400M
| $938K | ﹤0.01% |
48,700
-1,200
| -2% | -$23.1K |
|
2200
Columbia Financial
CLBK
$1.6B
| $932K | ﹤0.01% |
62,288
| – | – |
|